OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus
Ability to mass produce HPV may lead to gains against cervical cancer
July 4th, 2005
Researchers may be on the verge of exploiting the vulnerabilities of a virus that causes cervical cancer, thanks to a newly developed technique that enables scientists to mass-produce human papillomavirus (HPV) in the laboratory. HPV, which exists in more than 100 forms, is the most prevalent sexually transmitted infection in the U.S. Transmission of HPV can also occur nonsexually. According to the U.S. Centers for Disease Control and Prevention, approximately 20 million people in the United States are currently infected with HPV. At least 50% of sexually active men and women will acquire genital HPV infection at some point in their lives. By age 50, at least 80% of...
Source: OBGYN & Reproduction Week (2005-07-04)
|
